Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Dye vs. air: which better guides lung cancer surgery?

NCT ID NCT05453721

First seen May 07, 2026 · Last updated Jun 23, 2026 · Updated 13 times

Summary

This study compared two ways for surgeons to see the borders between lung segments during surgery for early-stage non-small cell lung cancer. One method uses a green dye and a special camera, the other uses a modified inflation-deflation technique. The trial involved 272 patients across multiple centers and measured how often each method successfully showed the segment border, as well as surgery time and blood loss. The goal is to provide evidence to help surgeons choose the best approach for precise lung-sparing surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEGMENTECTOMY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • The First Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, 330006, China

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Indocyanine green dye

What this could lead to

If successful, this could help surgeons choose the best method to identify lung segment boundaries, potentially improving surgery accuracy and recovery for early-stage lung cancer patients.

What could go wrong

This is a completed trial comparing two techniques, not testing a new treatment. The results may not change practice if one method is not clearly better, and findings may not apply to all patients or hospitals.

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.